Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if Myobloc significantly decreases
prosthesis-associated symptomatic sweating in amputees when compared to a saline solution
placebo. The study is randomized, double-blind, placebo-controlled, crossover trial with a
total enrollment of 32 amputee subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborator:
Walter Reed National Military Medical Center
Treatments:
Botulinum Toxins Botulinum Toxins, Type A rimabotulinumtoxinB